首页 » DIPG NTCC®人弥漫性真性脑桥神经胶质瘤细胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC Inc.

DIPG NTCC®人弥漫性真性脑桥神经胶质瘤细胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC Inc.

  • 价  格:¥98965
  • 货  号:NTCC®-DIPG
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

DIPG NTCC®人弥漫性真性脑桥神经胶质瘤细胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心


Diffuse intrinsic pontine glioma (DIPG) cells are tumor cells that originate in the glial cells of the pons, a part of the brain stem:

  • Characteristics
    DIPG cells are typically small and monomorphic, but can also be large and pleomorphic. They usually have an astrocytic morphology, but can also have an oligodendroglial morphology.
  • Location
    DIPG tumors infiltrate the grey and white matter structures of the brain.
  • Growth
    DIPG tumors grow quickly and spread to nearby tissue and other parts of the brain stem.
  • Treatment
    Radiation therapy can shrink the tumor and reduce pressure on the brainstem, which can improve a child's condition for a few months. Other treatments include bromodomain and extra-terminal domain (BET) inhibitors and histone deacetylase (HDAC) inhibitors.
  • Prognosis
    DIPG is a high-grade glioma that is considered incurable and has a poor prognosis. It is the leading cause of pediatric cancer-related death.

DIPG is rare in adults, but primarily affects children between the ages of 5 and 10 years. In the United States, about 300 children are diagnosed with DIPG each year.

Cell pictures:

SF8628 Human DIPG H3.3-K27M Ce | SCC127 | SIGMA-ALDRICH | SLS


BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

www.biovector.net

您正在向 biovector.net  发送关于产品 DIPG NTCC®人弥漫性真性脑桥神经胶质瘤细胞株Diffuse intrinsic pontine glioma cells-BioVector NTCC Inc. 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。